SLOAN SHELDON (Chief Medical Officer) sold 8.33K shares of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $625.0K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0001636282-26-000078
Officer· Chief Medical Officer
Since Oct 2024
-8.33K
Net shares
Net seller
$625.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.33K acquired · 16.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.33K
Price / share
$27.46
Trade value
$228.82K
% of position
New position
6/3/2026
0.00→8.33K
Common Stock
Direct
Shares
−8.33K
Price / share
$75.00
Trade value
$624.98K
% of position
New position
6/3/2026
8.33K→0.00
Total
Net shares
+0.00
Net value
-$396.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | M · Option Exercise | +8.33K | $27.46 | $228.82K | New position | 0.00 | 8.33K |
| Common Stock Direct | 6/3/2026 | S · Sale | −8.33K | $75.00 | $624.98K | New position | 8.33K | 0.00 |
| Total | +0.00 | -$396.15K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.33K shares
Shares
−8.33K
Strike price
27.46
Held after
313.33K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8.33K shares | 6/3/2026 | M · Option Exercise | −8.33K | 27.46 | — | 313.33K |